Long-term doxycycline-regulated secretion of erythropoietin by encapsulated myoblasts

Molecular Therapy

Volumn 6, Issue 2, 2002, Pages 155-161

  Sommer, Birgit ^a   Rinsch, Christopher ^a   Payen, Emmanuel ^b   Dalle, Bruno ^b   Schneider, Bernard ^a,c   Déglon, Nicole ^a,c   Henri, Annie ^b   Beuzard, Yves ^b   Aebischer, Patrick ^a,c  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b SAINT LOUIS HOSPITAL   (France)

^c EPFL   (Switzerland)

Author keywords

Encapsulation; Erythropoietin; Gene therapy; Tetracycline regulation

Indexed keywords

DOXYCYCLINE; DRINKING WATER; ERYTHROPOIETIN; TETRACYCLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOREGULATION; CELL CLONE; CELL ENCAPSULATION; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; DRUG RELEASE; ENCAPSULATION; FEMALE; GENE DELIVERY SYSTEM; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE TARGETING; GENE THERAPY; GENETIC ENGINEERING; HEMATOCRIT; HORMONE RELEASE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MYOBLAST; NONHUMAN; POLYCYTHEMIA; PROTEIN SECRETION;

ANIMALIA;

EID: 0036664621     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2002.0646     Document Type: Article

References (19)

1. Aebischer, P., et al. (1996). Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF. Hum. Gene Ther. 7: 851-860.
2. Aebischer, P., et al. (1996). Intrathecal delivery of CNTF using encapsulated genetically modified xenogenetic cells in amyotrophic lateral sclerosis patients. Nat. Med. 2: 696-699.
3. Buchser, E., et al. (1996). Immunoisolated xenogenic chromaffin cell therapy for chronic pain. Initial clinical experience. Anesthesiology 85: 1005-1012.
4. Deglon, N., et al. (1996). Central nervous system delivery of recombinant ciliary neurotrophic factor by polymer encapsulated differentiated C2C12 myoblasts. Hum. Gene Ther. 7: 2135-2146.
5. Regulier, E., Schneider, B. L., Deglon, N., Beuzard, Y., and Aebischer, P. (1998). Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts. Gene Ther. 5: 1014-1022.
6. Rinsch, C., et al. (1997). A gene therapy approach to regulated delivery of erythropoietin as a function of oxygen tension. Hum. Gene Ther. 8: 1881-1889.
7. Agha-Mohammadi, S., and Lotze, M. T. (2000). Regulatable systems: applications in gene therapy and replicating viruses. J. Clin. Invest. 105: 1177-1183.
8. Gossen, M., and Bujard, H. (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89: 5547-5551.
9. Gossen, M., and Bujard, H. (1995). Efficacy of tetracycline-controlled gene expression is influenced by cell type: commentary. BioTechniques 19: 213-216.
10. Bohl, D., and Heard, J. M. (1997). Modulation of erythropoietin delivery from engineered muscles in mice. Hum. Gene Ther. 8: 195-204.
11. Serguera, C., Bohl, D., Rolland, E., Prevost, P., and Heard, J. M. (1999). Control of erythropoietin secretion by doxycycline or mifepristone in mice bearing polymer-encapsulated engineered cells. Hum. Gene Ther. 10: 375-383.
12. Bohl, D., Naffakh, N., and Heard, J. M. (1997). Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts. Nat. Med. 3: 299-305.
13. Naffakh, N., et al. (1995). Sustained delivery of erythropoietin in mice by genetically modified skin fibroblasts. Proc. Natl. Acad. Sci. USA 92: 3194-3198.
14. Bohl, D., Salvetti, A., Moullier, P., and Heard, J. M. (1998). Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector. Blood 92: 1512-1517.
15. Rendahl, K. G., et al. (1998). Regulation of gene expression in vivo following transduction by two separate rAAV vectors. Nat. Biotechnol. 16: 757-761.
16. Svensson, E. C., et al. (1997). Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector. Hum. Gene Ther. 8: 1797-1806.
17. Rizzuto, G., et al. (2000). Gene electrotransfer results in a high-level transduction of rat skeletal muscle and corrects anemia of renal failure. Hum. Gene Ther. 11: 1891-1900.
18. Shockett, P. E., and Schatz, D. G. (1996). Diverse strategies for tetracycline-regulated inducible gene expression. Proc. Natl. Acad. Sci. USA 93: 5173-5176.
19. de la Luna, S., Soria, I., Pulido, D., Ortin, J., and Jimenez, A. (1988). Efficient transformation of mammalian cells with constructs containing a puromycin-resistance marker. Gene 62: 121-126.